Blog
RSS FeedPosted by Michael Wonder on 09 Aug 2021
Scotland backs Bavencio for bladder cancer after NICE says no
9 August 2021 - Patients with bladder cancer in Scotland will be the first in the UK to claim access ...
Posted by Michael Wonder on 14 Jul 2021
Kesimpta (ofatumumab) approved for relapsing remitting MS in Scotland
12 July 2021 - The SMC has recommended that Kesimpta can be prescribed for people with relapsing remitting multiple sclerosis who ...
Posted by Michael Wonder on 13 Jul 2021
Tecentriq, Kesimpta lead latest SMC decisions
13 July 2021 - The SMC has accepted three new medicines for use by NHS Scotland and rejected one in its ...
Posted by Michael Wonder on 12 Jul 2021
SMC - July 2021 decisions
12 July 2021 - The SMC has today published advice accepting three new medicines. ...
Posted by Michael Wonder on 07 Jun 2021
SMC - June 2021 decisions
7 June 2021 - Advice on five new medicines for use in conditions including advanced gastric cancer and chronic lymphocytic leukaemia ...
Posted by Michael Wonder on 10 May 2021
Medicines for colorectal, skin and ovarian cancers approved for NHS Scotland use
10 May 2021 - The Scottish Medicines Consortium accepted a treatment of colorectal cancer in patients with a gene mutation called ...
Posted by Michael Wonder on 10 May 2021
SMC - May 2021 decisions
10 May 2021 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has announced today that ...
Posted by Michael Wonder on 13 Apr 2021
Scotland opens door to Translarna for Duchenne muscular dystrophy
13 April 2021 - A disparity in UK access to a medicine for Duchenne muscular dystrophy has been addressed, after ...
Posted by Michael Wonder on 13 Apr 2021
Four medicines accepted for use by NHS Scotland
13 April 2021 - The Scottish Medicines Consortium has approved NHS funding for four new medicines, including treatments for multiple ...
Posted by Michael Wonder on 12 Apr 2021
SMC - April 2021 decisions
12 April 2021 - Advice on four new medicines for use in conditions including multiple myeloma and severe migraine has today ...
Posted by Michael Wonder on 08 Mar 2021
SMC - March 2021 decisions
8 March 2021 - Medicines which can be used to treat a rare genetic disease in children and some cancer ...
Posted by Michael Wonder on 09 Feb 2021
Scottish Medicines Consortium accepts Prostap SR DCS & Prostap 3 DCS (leuprorelin acetate) to treat early and advanced breast cancer
8 February 2021 - Takeda is pleased to announce that the Scottish Medicines Consortium has accepted Prostap SR DCS & ...
Posted by Michael Wonder on 09 Feb 2021
Scottish approval of a new treatment for people with chronic obstructive pulmonary disease - formoterol fumarate dihydrate/glycopyrronium bromide/budesonide
8 February 2021 - AstraZeneca today announced that Trixeo Aerosphere (formoterol fumarate/glycopyrronium bromide/budesonide) is now accepted for use by the SMC ...
Posted by Michael Wonder on 09 Feb 2021
SMC issues positive decision for treatment with AbbVie’s Rinvoq (upadacitinib) in severe active rheumatoid arthritis
9 February 2021 - Positive indication means upadacitinib will be available to those with previously treated severe active rheumatoid arthritis. ...
Posted by Michael Wonder on 09 Feb 2021
Scotland approves MS drug that was rejected in England and Wales
9 February 2021 - A drug that can reduce the number of relapses suffered by people with multiple sclerosis has been ...